McKesson Corporation (MCK) is experiencing ongoing investor interest due to consistent financial performance and strategic moves. The most recent fiscal quarterly and full year results for 2025 have been reported, and guidance for 2026 has been provided. Several of the top executives, including Thomas Rodgers and LeAnn B. Smith, have reportedly sold substantial amounts of MCK stock. Meanwhile,
insider selling from other executives including the CFO Vitalone and CEO Tyler has also been noted. The company has made significant moves in the form of spinning off its
Medical-Surgical Solutions business, issuing $2 billion notes for an acquisition, and completing a purchase of
PRISM Vision Holdings. The stock has shown strong growth momentum and has been labeled a 'Trump Stock' by Jim Cramer, he also calls MCK a 'Money Machine,' indicating it's a must-own middling investment. Despite missing some quarterly revenue estimates, the company's
long-term growth potential remains robust.
Mckesson Corporation MCK News Analytics from Thu, 05 Sep 2024 07:00:00 GMT to Fri, 30 May 2025 18:14:11 GMT -
Rating 8
- Innovation 5
- Information 7
- Rumor -3
